Targeted liposomal doxorubicin/ceramides combinations: The importance to assess the nature of drug interaction beyond bulk tumor cells.
2022-07-06
2022. Cruz AF, Fonseca NA, Malheiro AR, Melo JB, Gaspar MM, Fernandes R, … & Moreira JN. European Journal of Pharmaceutics and Biopharmaceutics, 172, 61-77.
